The Food and Drug Administration has not evaluated these statements. This product is not designed to diagnose, treat, cure, or prevent any medical condition. Not intended for human consumption.
Tesamorelin is a synthetic 44–amino acid analog of growth hormone–releasing hormone (GHRH), engineered for increased structural stability and receptor affinity. It is examined for its ability to activate GHRH receptors in the anterior pituitary, thereby influencing endogenous growth hormone (GH) signaling pathways in research settings. Experimental studies use Tesamorelin to investigate GH-pulsatility patterns, IGF-1–related regulatory mechanisms, and metabolic pathways associated with lipid turnover and insulin-signaling dynamics.
Image 1 of 1
